Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30-Reference-Cited by-同舟云学术

Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30

Published:2012-07 Issue:11 Volume:48 Page:1713-1721
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Cocks K.,King M.T.,Velikova G.,de Castro G.,Martyn St-James M.,Fayers P.M.,Brown J.M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30 [comment];Fayers;Eur J Cancer,2001

3. Quality of life of Danish women: population-based norms of the EORTC QLQ-C30;Klee;Qual Life Res,1997

5. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population;Schwarz;Eur J Cancer,2001

Cited by 377 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of social care nurses on health related quality of life in patients with advanced cancer: A non-randomized, multicenter, controlled trial;Quality of Life Research;2024-09-13

2. Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial;The Lancet Oncology;2024-09

3. Impact of a Multidisciplinary Supportive Care Model Using Distress Screening at an Asian Ambulatory Cancer Center: A Cluster Randomized Controlled Trial;JCO Oncology Practice;2024-09

4. Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma;Journal of Clinical Oncology;2024-08-10

5. Robotic versus laparoscopic hepatectomy for liver malignancies (ROC'N'ROLL): a single-centre, randomised, controlled, single-blinded clinical trial;The Lancet Regional Health - Europe;2024-08